Aims Chronic heart failure (CHF) leads to pulmonary vascular remodelling and thickening of the alveolocapillary barrier. We examined whether this protective effect may slow resolution of pulmonary oedema consistent with decreased bidirectional fluid flux.
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Introduction
Acute left ventricular dysfunction usually leads to an acute elevation of pulmonary microvascular pressure (Pmv) followed by acute pulmonary oedema (APO). However, chronic elevations in Pmv lead to muscularisation of the pulmonary circulation, thickening of the alveolocapillary barrier, and a reduction in the capillary filtration coefficient with amelioration of the increase in lung water 1 . Indeed, 6 weeks following myocardial infarction in the rat an average left ventricular end diastolic pressure (LVEDP) of 25mmHg, which would be expected to result in APO, leads only to an increase in lung dry weight 2 . In addition to this decrease in fluid egress due to reduced capillary filtration coefficient, an increase in alveolar fluid clearance may also contribute to the dry lung when Pmv is chronically elevated 3 . However, gas diffusion and alveolar-membrane conductance are reduced in CHF patients 4 consistent with a thickened alveolocapillary barrier, and reduced solute clearance from the alveolus.
Alveolar fluid is regulated by active ion transport followed by passive water movement 5 .
Vectorial ion movement out of the alveolus through the epithelium occurs via apically placed amiloride sensitive cation channels (ENaC) and basolateral oubain inhibitable Na,K-ATPase, which pump K into the cell and Na out. In addition, aquaporins (AQP), integral membrane proteins found on both epithelial and endothelial cells, function as bi-directional water channels.
As chronic elevation of Pmv leads to lung remodelling that is associated with reduced capillary filtration coefficient we hypothesised that intrinsic alveolar fluid clearance, independent of circulating factors, may be reduced. However, previous studies have suggested both downregulated [6] [7] [8] [9] [10] and upregulated vectorial fluid flux, perhaps due to elevated circulating catecholamines 11, 12 . Therefore the aim of this study was to examine bi-directional fluid regulation, including factors affecting vectorial fluid movement, in the well established rodent 
Elevated Left Atrial Pressure
In isolated perfused lungs (IPL; n=29) lung impedance, following a forced oscillation, was measured sequentially at 0, 5, 10, 15 and 20 cmH 2 0 left atrial pressure, referenced to the top of the lung, before determination of fluid flux.
Alveolar Fluid Clearance Measurement
In a second cohort of isolated rat lungs (n=47) alveolar fluid clearance (AFC) was measured via
Evan's Blue dye concentration calculated as follows:
where V is the volume of instilled albumin solution (i) and final alveolar fluid (f), and
where EB is the concentration of Evans blue dye in the instilled albumin solution (i) and final alveolar fluid (f).
Lung Tissue Analysis
Right lung lobes were freeze-dried for measurement of wet-to-dry weight ratio, tissue NO and for α-and β-Na,K-ATPase subunits, α-, β-and γ-ENaC, AQP1, AQP5 and nitric oxide synthase (NOS) mRNA levels by qRT-PCR (Supplementary material online, Table S1 ), before lavage of the remaining lung for assay of soluble proteins 2 .
Immunohistochemistry was used to identify alveolar epithelial type II cells and AQP1
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Clinical subjects
Sixteen consecutive patients, admitted to the Intensive Care Unit with APO, defined as sudden onset of dyspnoea and diaphoresis with tachycardia, tachypnea, hypertension, widespread pulmonary crepitations, and acute respiratory failure, in the absence of fever, were enrolled following informed consent at Flinders Medical Centre, South Australia. Patient demographics, haemoglobin and creatinine, and arterial blood gas were analyzed at ICU presentation and after 24 hours. Patients with significant renal impairment, defined as a baseline creatinine greater than 250 µM/L or receiving chronic dialysis, were excluded. The percentage changes in plasma volume (PV) were calculated using haemoglobin (Hb) before (B) and after (A) treatment 15 .
% change in PV = 100 x (1 − (HbA/HbB))
Statistical Analyses
Statistical analyses were performed using SPSS 18.0 (PASW Inc, Chicago, IL) unless indicated.
One-way analysis of variance was used to compare three groups, with between group differences tested with either Tukey's HSD or independent samples t test. Bivariant relationships were examined using Pearson's correlation or quadratic regression curve fit model. Repeated measures were predicted using mixed-effects linear regression (Supplementary material online, 0.772, P ≤ 0.001). As previously 2 , the large infarct group with an LVEDP approximating 24mmHg resulted in an increase in dry lung weight without lung oedema ( Table 1) . Table 2) . Observed versus predicted outcomes by mixed models analysis is included in the online supplemental material (Supplementary material online, Figure S1 & Table S3 ).
Effect of Acute Elevation in Left Atrial Pressure in Isolated Perfused
Effect of Increasing Left Ventricular Dysfunction on Alveolar Fluid Clearance
Archived at Flinders University: dspace.flinders.edu.au No relationship was found between either infarct size or alveolar fluid clearance and ENaC-α, ENaC-β or ENaC-γ, Na,K-ATPase-α or Na,K-ATPase-β, or AQP5 (Supplementary material online, Table S4 ). The expression ratio of ENaC-α:β:γ was approximately 150:1:6, while the expression ratio of Na,K-ATPase-α:β was 3.7:1 and did not alter with LV dysfunction (P > 0.05).
Effect of Left Ventricular Dysfunction on Mediators of Pulmonary Fluid Regulation
Concentrations of soluble mediators of alveolar fluid clearance (TNF-α, TGF-β, NO) were not related to either LV dysfunction (LV infarct >20) or alveolar fluid clearance (Supplementary material online, Table S5 ). Similarly, there was no change in the mRNA expression of either inducible or constitutive nitric oxide synthase (NOS) with LV dysfunction or alveolar fluid clearance (Table S5 ).
Archived at Flinders University: dspace.flinders.edu.au
Plasma Volume Change in Clinical APO in CHF and non-CHF patients
APO patients with a prior clinical history of CHF (n=8) and those without (non-CHF, n=8) were similar in age, gender, severity of illness and respiratory dysfunction at ICU admission ( Table 3) .
CHF patients had a lower left ventricular ejection fraction. Non-CHF patients were more acidotic with higher arterial PCO 2 than CHF patients; plasma lactate was elevated equally in both groups. More CHF patients than non-CHF were taking furosemide prior to admission. Plasma volume was significantly increased 24h following ICU admission in all APO patients. However, the percent change in plasma volume was significantly lower in the CHF patients when compared with non-CHF patients.
Discussion
Chronic elevation in Pmv due to left ventricular dysfunction results in pulmonary parenchymal remodelling which protects against the development of pulmonary oedema 1, 2 . Despite this, APO in response to acute elevations of Pmv is a common clinical issue. We examined intrinsic bidirectional fluid flux in the lung following chronic elevation of Pmv due to left ventricular dysfunction and observed both increased tolerance to acute left atrial pressure elevation and impaired clearance of extraneous lung fluid. We also report a decrease in endothelial AQP1 that correlates with the reduction in alveolar fluid clearance, and an increase in dry lung weight that we have previously found to correlate with lung collagen 2 . These data are consistent with Three alternative mediators of alveolar fluid regulation were also examined. NO and TGF-β1 which decrease alveolar fluid clearance via inhibition of Na + transport and ENaC, respectively, and TNF-α, which increases or decreases fluid clearance in a concentration and temporal relationship 9, [18] [19] [20] . While no association with tissue NO or NOS was found in the 9 current study, at 16 weeks following left coronary artery ligation in the rat NO synthesis by endothelial cells has been reported to be impaired, possibly restoring the rate of alveolar fluid clearance 16, 21 . TNF-α is a pro-inflammatory cytokine that plays an important role in the activation of host defence, and is associated with increased mortality in CHF patients. In vitro TNF-α inhibits Na + transport and down regulates ENaC activity and protein expression in isolated rat alveolar epithelial cells 20 , while in vivo TNF-α is associated with an increase of alveolar fluid clearance 22 . However, no change in alveolar TNF-α was found in our rat model at Aquaporins are fundamental to the maintenance of fluid homeostasis. AQP1, AQP4 and AQP5 are predominant in the lung on endothelium, airway epithelium and alveolar epithelium, respectively. Expression of lung AQP appears to be regulated by inflammation via corticosteroids and cytokines. AQP1 knockout produces greater than 10-fold decrease in microvascular and alveolar-capillary water permeability resulting in decreased hydrostatic lung oedema 25 . However, AQP1 does not affect alveolar fluid clearance in models of acute lung injury 26 . Expression of lung endothelial AQP1 is decreased in models of viral infection, pulmonary fibrosis and, recently, consistent with our results, in CHF [27] [28] [29] .
Differential expression
Archived at Flinders University: dspace.flinders.edu.au patterns of AQP1 to AQP5 in each of these models with resultant change in pulmonary oedema support an independent role for AQP1 in prevention of capillary filtration. However, as a decrease in endothelial AQP1 in the absence of concurrent changes in epithelial sodium channels and AQP5 would seem insufficient to explain the reduction in alveolar fluid clearance, we suggest that structural remodelling is likely to be the major component. Indeed, a similar paradigm is recognised both clinically and experimentally in the diabetic lung whereby protection against ARDS may be attributed to thickened endothelial and epithelial basement membranes 30, 31 , while diabetic CHF patients exhibit a more severe reduction in alveolocapillary membrane conductance than those with CHF alone 32 .
Alveolar fluid clearance was strongly and inversely related to both the size of the myocardial infarct and LVEDP, and more weakly inversely related to dry lung weight. Given the lack of correlation between alveolar fluid clearance and ion channels or mediators of alveolar fluid regulation, and the previously reported correlation between dry lung weight and collagen content 2 , we suggest that basement membrane structural changes most likely explain this decrease. As deletion of AQP1 does not influence alveolar fluid clearance, perhaps due to fluid accumulation in the interstitium, this is likely to have a lesser contribution, if any.
Maron and coworkers 16 reported that alveolar fluid clearance was increased with β- in alveolar fluid clearance we report is not directly related to alveolar type II cell prevalence.
Plasma volume restoration following an episode of APO was estimated to be less in patients with CHF, consistent with reduced alveolar fluid clearance. These data derive from a previously validated methodology 13 which is indirect in that it assumes haemoconcentration as a result of APO, and is therefore not definitive. Patients without CHF may rapidly reduce Pmv with treatment of myocardial ischemia or hypertension leading to a reversal of the hydrostatic gradient. This gradient was not measured as few patients had pulmonary artery catheters placed.
However, the changes in Pmv with APO can be extremely rapid and may have normalised prior to catheter placement, despite the prolonged phase of increased extravascular lung water 33 .
Patients without a history of CHF were more acidaemic possibly consistent with higher acuity and higher circulating catecholamine levels which might have led to increased alveolar fluid flux. As both groups had similar impairment in oxygenation and similar elevations in plasma lactate, which we have previously found strongly correlated with plasma epinephrine and norepinephrine, 34 this mechanism seems a less likely explanation for the difference found in plasma volume restoration. However, we did not measure catecholamine levels in the current study.
Given the prevalence, morbidity and mortality from CHF, specifically APO, all possible interventions should be examined. The interface between the failing heart and the lung, the alveolocapillary barrier, offers a direct target for investigation and intervention in decompensated heart failure, particularly following a decade of disappointing acute cardio-renal interventions 35 .
Furthermore, the independent impact of pulmonary hypertension on mortality in CHF supports the importance of the heart lung interaction in this complex syndrome 36 . The reduction in alveolar fluid clearance in CHF suggested by our data, and consequent prolonged period of alveolar oedema, extends our understanding of the pathophysiologic challenges in managing 12 decompensated heart failure patients.
This study had limitations which should be addressed in future projects. While the literature on AQP1 knockout animals supports our hypothesis that a decrease in these channels is not the primary mechanisms for decreased alveolar fluid clearance, this was not directly assessed. Studies using AQP1 agonists and antagonists should be undertaken in this model as these become available. Further, a lack of change in ion channels, AQP5 or NOS mRNA does not exclude the possibility of changes at the protein or functional level. Clinically, we estimated that plasma volume restoration following 24 hours of cardiorespiratory support subsequent to an episode of APO was less in patients with CHF, consistent with reduced alveolar fluid clearance.
While this methodology was indirect and patient numbers relatively small, the finding of reduced haemodilution in CHF in the absence of differences in fluid balance is consistent with the invasive animal data. This result should be confirmed in a clinical study utilising a direct method that examines alveolar fluid clearance and the effect of confounders.
Our data support the hypothesis of a decrease in intrinsic bi-directional fluid flux at the alveolar capillary barrier where an elevation in Pmv is long standing, which may both protect against the development of pulmonary oedema, and contribute to its slow resolution once fluid has breached the alveolus. Given the clinical relevance of plasma refill rate 35 and extravascular lung water in the management of heart failure, our observations may have direct clinical relevance and warrant further investigation.
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